Gallbladder Cancer: A Comprehensive Guide to Management
Sold by Biblios, Frankfurt am main, HESSE, Germany
AbeBooks Seller since 10 September 2024
New - Soft cover
Condition: New
Ships from Germany to U.S.A.
Quantity: 4 available
Add to basketSold by Biblios, Frankfurt am main, HESSE, Germany
AbeBooks Seller since 10 September 2024
Condition: New
Quantity: 4 available
Add to basketGallbladder Cancer: A Comprehensive Guide to Management was planned as a thorough, yet objective text about gallbladder cancer, encompassing from epidemiology and pathogenesis to the present cutting edge technology and ongoing research.
This work provides a comprehensive review of a worldwide scope disease as a collaboration of renowned researchers from different continents, including the latest discussions of crucial topics on gallbladder cancer management.
The epidemiology content covers epidemiologic data, trends over time, risk factors, incidence and cancer specific mortality rates. Chapters describe the intrinsic molecular mechanisms of oncogenesis associated with the pathogenetic mechanisms, genomics, proteomics and transcriptomics. Regarding prevention, prophylactic measures and preventive use of drugs is presented. Chapters also describe the clinical, radiological, laboratorial aspects of the different forms of gallbladder cancer. In addition, the role of biomarkers for diagnosis, prognosis and follow up is explored. Readers will also find topics such as management through multidisciplinary treatment, surgical controversies, systemic therapy and radiation therapy.
The book is a valuable resource to general and cancer surgeons, HPB surgeons, clinical oncologists, gastroenterologists and medical residents.
Mauro M. Correia, MD, PhD: MD from the Federal University of Rio de Janeiro State (Unirio, Brazil, 1984). He completed residencies in general surgery at UFRJ (1987) and in surgical oncology at the National Cancer Institute (Brazil, 1989). Master (1991) and PhD (1997) in general surgery from the Federal University of Rio de Janeiro (UFRJ, Brazil). Oncologic Digestive Endoscopy fellowship at UFF-INCA (1990). Observation HPB Fellow Scholarship at Memorial Sloan Kettering Cancer Center (USA, 1995). Postdoctoral fellowship at Wakefield Clinic (New Zealand, 2004). He coordinated the Medical Residency Program at the National Cancer Institute (Brazil), where he also founded the Liver Group and introduced ablative methods and IOUS. He founded the Brazilian Chapter of the IHPBA. He is a fellow of the Brazilian College of Surgeons, Emeritus President of the Brazilian Chapter of IHPBA and fellow of the Brazilian Society of Surgical Oncology. He has been head of the Surgical Department at UNIGRANRIO University for 23 years. His research has contributed to developing medical educational imaging, navigated liver surgery with augmented reality and epidemiological research on colorectal liver metastases. Dr Correia has coordinated the production of the first Treatise of Oncology in Brazil, gathering 400 national and international collaborators in 2013 and is author to other 10 books and 46 book chapters in Portuguese, Spanish and English in the area of Surgical Oncology (Gastric Cancer; Hepatobiliary Cancer Surgery). He has also written many scientific papers and is member of the editorial board of the REVISTA BRASILEIRA DE CANCEROLOGIA and ACTA SCIENTIAE ANATOMICA.
Michael A. Choti, MD: Dr. Choti received his MD degree from Yale University, general surgery training at the University of Pennsylvania, and completed the surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center before joining the division of Surgical Oncology at Johns Hopkins. Among his leadership roles, he was the Chair of Surgery at the University of Texas Southwestern Medical Center. Currently, he is the Chief of Surgery at Banner MD Anderson Cancer Center in Phoenix, Arizona. Dr. Choti is an active clinician and researcher with an interest in new approaches for the treatment of liver and colorectal cancer. He has served on various leadership positions in national and international societies and has chaired study sections for the American Cancer Society. He served as Chair of the NCI-CTEP Hepatobiliary Task Force as well as on the American College of Surgeons’ Commission on Cancer, the GI committees of NSABP and ACOSOG, and the Colorectal Cancer Guideline Panel of NCCN. He has directed educational symposia and served on program committees for ASCO, SSO, AACR, among others. He also was a Section Editor for the Annals of Surgical Oncology. Currently, he is on the Surgical Oncology Board for the American Board of Surgery.
Dr. Rocha, is the Hedinger Professor and Chair of Surgical Oncology at Oregon Health and Science University (OHSU) in Portland, OR. He also serves as the Physician-in-Chief of the Knight Cancer Institute at OHSU. He graduated with honors from the University of Chicago Pritzker School of Medicine. After training in general surgery at the Brigham and Women’s Hospital and Harvard Medical School both in Boston, he completed both a surgical oncology and hepatopancreatobiliary surgery fellowship at Memorial Sloan-Kettering Cancer Center in New York City. He spent ten years practicing in Seattle prior to moving to Oregon in 2021. Dr. Rocha’s clinical practice encompasses all aspects of benign and malignant disease of the liver, bile ducts and pancreas. He has been funded by the AAS, NIH/NIDDK, ASCO and the Cholangiocarcinoma Foundation. Dr. Rocha currently sits on the editorial boards of Surgery, HPB, Annals of Surgical Oncology, and Journal of Surgical Oncology. He has served on the NCI Pancreas Task Force, ASCO Gastrointestinal Cancers Advisory Council and ASTRO Liver Cancer Guidelines Committee. He is currently the surgical lead of the International Cholangiocarcinoma Research Network (ICRN), Vice-Chair of the Southwest Oncology Group (SWOG) Surgery Committee, GI Surgery Working Group Chair at Eastern Cooperative Group (ECOG-ACRIN) and Chair of the Cancer Standards Development Committee at the American College of Surgeons.
"About this title" may belong to another edition of this title.
If you are a consumer you can cancel the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
INFORMATION REGARDING THE RIGHT OF CANCELLATION
Statutory Right to cancel
You have the right to cancel this contract within 14 days for any reason.
The cancellation period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the the last good or the last lot or piece.
To exercise the right to cancel, you must inform us, Biblios, 47 Kaisetstrasse, 60329, frankfurt am main, hessen, Germany, of your decision to cancel this contract by a clear statement (e.g. a letter sent by post, fax or e-mail). You may use the attached model cancellation form, but it is not obligatory. You can also electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". If you use this option, we will communicate to you an acknowledgement of receipt of such a cancellation on a durable medium (e.g. by e-mail) without delay.
To meet the cancellation deadline, it is sufficient for you to send your communication concerning your exercise of the right to cancel before the cancellation period has expired.
Effects of cancellation
If you cancel this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to cancel with contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to us or Biblios, 47 Kaisetstrasse, 60329, frankfurt am main, Germany, without undue delay and in any event not later than 14 days from the day on which you communicate your cancellation from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of cancellation
The right of cancellation does not apply to:
Model withdrawal form
(complete and return this form only if you wish to withdraw from the contract)
To: (Biblios, 47 Kaisetstrasse, 60329, frankfurt am main, hessen, Germany)
I/We (*) hereby give notice that I/We (*) withdraw from my/our (*) contract of sale of the following goods (*)/for the provision of the following goods (*)/for the provision of the following service (*),
Ordered on (*)/received on (*)
Name of consumer(s)
Address of consumer(s)
Signature of consumer(s) (only if this form is notified on paper)
Date
* Delete as appropriate.
| Order quantity | 25 to 45 business days | 8 to 14 business days |
|---|---|---|
| First item | £ 8.63 | £ 16.23 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.